Get the Stockscreener App
0.5795
0.02%
-0.000100
After Hours:
.59
0.0105
+1.81%
Docgo Inc stock is traded at $0.5795, with a volume of 542.38K.
It is down -0.02% in the last 24 hours and up +1.47% over the past month.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
See More
Previous Close:
$0.5796
Open:
$0.5804
24h Volume:
542.38K
Relative Volume:
0.56
Market Cap:
$57.24M
Revenue:
$301.71M
Net Income/Loss:
$-201.99M
P/E Ratio:
-0.3027
EPS:
-1.9144
Net Cash Flow:
$13.79M
1W Performance:
+6.31%
1M Performance:
+1.47%
6M Performance:
-37.01%
1Y Performance:
-60.03%
1-Day Range:
$0.5688
$0.6262
1-Week Range:
$0.5306
$0.6262
52-Week Range:
$0.4913
$1.7799
Docgo Inc Stock (DCGO) Company Profile
Name
Docgo Inc
Sector
Industry
Phone
(844) 443-6246
Address
685 THIRD AVENUE, NEW YORK
Compare DCGO vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCGO
Docgo Inc
|
0.5795 | 57.25M | 301.71M | -201.99M | 13.79M | -1.9144 |
HCA
Hca Healthcare Inc
|
389.97 | 85.89B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
179.11 | 15.04B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
209.75 | 13.39B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.45 | 12.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
99.36 | 10.07B | 6.07B | 793.80M | 464.40M | 5.9914 |
Docgo Inc Stock (DCGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-28-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-18-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Jan-19-22 | Initiated | Stifel | Buy |
| Dec-21-21 | Initiated | Canaccord Genuity | Buy |
| Dec-07-21 | Initiated | Needham | Buy |
View All
Docgo Inc Stock (DCGO) Latest News
DocGo Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesSegment Revenue Breakdown - newsline.com
DocGo launches mobile phlebotomy services in southern Florida By Investing.com - Investing.com India
DocGo launches mobile phlebotomy services in southern Florida - Investing.com
DocGo Launches Mobile Phlebotomy Services in South Florida - Business Wire
At-home blood draws come to South Florida as DocGo expands - Stock Titan
DocGo Inc. (DCGO) Edges Upward Amidst Narrow Trading RangeNegative Gamma - newsline.com
DocGo Q1 2026 Earnings: EPS Misses Estimates as Losses WidenInvestor Earnings Call - thelegaladvocate.com
DocGo (DCGO) price target decreased by 10.71% to 1.91 - MSN
DocGo targets profitability as it pivots to mobile health, medical transport - MSN
DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire
DocGo Inc. (DCGO) Q1 2026 Earnings: Wider-Than-Expected Loss Pressures SharesSocial Flow Trades - Newser
DocGo Inc. (DCGO) Navigates Resistance at $0.63 as Shares Edge LowerWeak Sell Signals - thelegaladvocate.com
DocGo outlines $310M-$315M 2026 revenue outlook while targeting 75% mobile phlebotomy growth - MSN
How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation Targets - Yahoo Finance
DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport - sharewise.com
DocGo Inc.Common Stock (NQ: DCGO - The Chronicle-Journal
US$1.87: That's What Analysts Think DocGo Inc. (NASDAQ:DCGO) Is Worth After Its Latest Results - Sahm
DocGo (DCGO) CEO sees 15,644 RSU shares withheld for tax liability - Stock Titan
DocGo Inc. (DCGO) reports Q1 loss, beats revenue estimates - MSN
DocGo Earnings Call: Growth Surges as Margins Strain - TipRanks
Needham Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $3 - Moomoo
CCORF Maintains DocGo(DCGO.US) With Hold Rating, Maintains Target Price $1 - Moomoo
BTIG Maintains DocGo(DCGO.US) With Hold Rating - Moomoo
Needham reiterates DocGo stock rating on SteadyMD strength By Investing.com - Investing.com South Africa
Needham reiterates DocGo stock rating on SteadyMD strength - Investing.com
DocGo Q1 Earnings Call Highlights - sharewise.com
DocGo Inc. (DCGO) Reports Q1 Loss, Beats Revenue Estimates - sharewise.com
MSN Money - MSN
Earnings call transcript: DocGo’s Q1 2026 results show revenue beat but EPS miss By Investing.com - Investing.com South Africa
Earnings call transcript: DocGo’s Q1 2026 results show revenue beat but EPS miss - Investing.com Nigeria
DCGO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
DocGo (DCGO) Q1 2026 Earnings Transcript - The Globe and Mail
DocGo Announces First Quarter 2026 Results - Business Wire
DocGo (NASDAQ:DCGO) Rallies on Strong Core Growth as Migrant Revenue Winds Down - ChartMill
DocGo (NASDAQ: DCGO) Q1 2026 revenue falls, covenant worries emerge - Stock Titan
Docgo Inc Stock (DCGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):